Timing of onset of antidepressant response with fluoxetine treatment

被引:193
作者
Nierenberg, AA [1 ]
Farabaugh, AH [1 ]
Alpert, JE [1 ]
Gordon, J [1 ]
Worthington, JJ [1 ]
Rosenbaum, JF [1 ]
Fava, M [1 ]
机构
[1] Massachusetts Gen Hosp, Depress & Clin Res Program, Boston, MA 02114 USA
关键词
D O I
10.1176/appi.ajp.157.9.1423
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: The purpose of this study was to assess the time until onset of antidepressant response with fluoxetine treatment. Method: The authors evaluated 182 outpatients with major depression who had a sustained acute response to fluoxetine treatment. The Outpatients received 8 weeks of treatment with 20 mg/day of fluoxetine and were assessed biweekly with the 17-item Hamilton Depression Rating Scale. The onset of response was defined as a 30% decrease in score on the Hamilton depression scale that persisted and led to a 50% decrease by week 8. The Kaplan-Meier product limit and Cox regression analysis were used to model the relationship between relevant variables and time until onset of response. Results: The authors found that at weeks 2, 4, and 6, the probabilities of having an onset of response (for responders) were 55.5%, 24.7%, and 9.3%, respectively. The cumulative probabilities of onset of response at each time point were 55.5%, 80.2%, and 89.5%,Neither demographics nor clinical characteristics of depression predicted time until initial response. Conclusions: These data suggest that more than half of eventual responders to fluoxetine treatment at 8 weeks start to respond by week 2; over 75% start to respond by week 4. Conversely, the lack of onset of response at 4-6 weeks was associated with about a 73%-88% chance that patients would not have an onset of response by 8 weeks.
引用
收藏
页码:1423 / 1428
页数:6
相关论文
共 34 条
[1]   IS A CUTOFF SCORE A SUITABLE MEASURE OF TREATMENT OUTCOME IN SHORT-TERM TRIALS IN DEPRESSION - A METHODOLOGICAL METAANALYSIS [J].
ANGST, J ;
DELINISTULA, A ;
STABL, M ;
STASSEN, HH .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 1993, 8 (05) :311-317
[2]   RAPID DOWN REGULATION OF BETA-ADRENOCEPTORS BY CO-ADMINISTRATION OF DESIPRAMINE AND FLUOXETINE [J].
BARON, BM ;
OGDEN, AM ;
SIEGEL, BW ;
STEGEMAN, J ;
URSILLO, RC ;
DUDLEY, MW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 154 (02) :125-134
[3]  
CHOUINARD G, 1985, J CLIN PSYCHIAT, V46, P32
[4]  
DERIVAN AT, 1995, PSYCHOPHARMACOL BULL, V31, P23
[5]  
FABRE LF, 1985, J CLIN PSYCHIAT, V46, P521
[6]  
FEIGHNER JP, 1985, J CLIN PSYCHIAT, V46, P20
[7]  
FRANK E, 1990, ARCH GEN PSYCHIAT, V47, P1093
[8]   ANALYSIS OF TIME TO STABILIZATION IN THE TREATMENT OF DEPRESSION - BIOLOGICAL AND CLINICAL CORRELATES [J].
GREENHOUSE, JB ;
KUPFER, DJ ;
FRANK, E ;
JARRETT, DB ;
REJMAN, KA .
JOURNAL OF AFFECTIVE DISORDERS, 1987, 13 (03) :259-266
[9]   A RATING SCALE FOR DEPRESSION [J].
HAMILTON, M .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) :56-62
[10]  
HEKIMIAN LJ, 1983, J CLIN PSYCHIAT, V44, P248